01 1Hubei Biocause Heilen Pharmaceutical Co., Ltd
01 1ABIRATERONE ACETATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-08-09
Pay. Date : 2022-06-16
DMF Number : 27853
Submission : 2013-12-24
Status : Active
Type : II
20
Hubei Biocause Heilen Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ABIRATERONE ACETATE, with a corresponding US DMF Number 27853.
Remarkably, this DMF maintains an Active status since its submission on December 24, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 09, 2022, and payment made on June 16, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
